Lumida
/LEU
⌘K
Centrus Energy Corp

Centrus Energy Corp

LEU
$156.05USD+6.11%+8.98 today

MARKET CAP

3.1B

P/E (TTM)

43.1x

FWD P/E

38.1x

DAY RANGE

$142 – $158

52W RANGE

$142
$464

AI Summary

Stalk
TrimMedium

LEU remains in a Stage 4 decline with persistent lower highs and lower lows below declining short- and intermediate-term EMAs. Medium-term bias is bearish, while short-term shows an oversold bounce but no clear rally acceptance above EMAs. Execution is best deferred, looking to trim into rallies at the 9/21 EMA and prior minor highs.

  • 2025 revenue $448.7M (+1.5% YoY) with $3.8B backlog through 2040
  • $900M DOE HALU contract funds expanded enrichment capabilities
  • Negative earnings yield raises overvaluation and value-trap concerns
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Centrus Energy Corp. (NYSE: LEU) is a leader in the nuclear fuel enrichment sector focusing on low-enriched uranium (LEU) and high-assay low-enriched uranium (HALU) production. The company is uniquely positioned in response to growing demand for domestic nuclear energy and national security, bolstered by recent government support and significant funding initiatives. With strategic investments in advanced manufacturing and a multi-billion dollar backlog, Centrus aims to capitalize on the ongoing nuclear renaissance.

Bull says

  • 2025 revenue $448.7M (+1.5% YoY) with $3.8B backlog through 2040
  • $900M DOE HALU contract funds expanded enrichment capabilities
  • High profitability (gross profit $117.5M; net income $77.8M) and $2B cash buffer
  • Strong growth factor from rising domestic nuclear energy demand
  • Positive momentum and high interest-rate sensitivity support stock appeal
  • Exclusive HALU expertise and low volatility strengthen competitive moat

Bear says

  • Negative earnings yield raises overvaluation and value-trap concerns
  • High short interest and elevated volatility deter stability-seeking investors
  • Heavy reliance on DOE funding creates regulatory and timing risks
  • Quarterly revenues and margins fluctuate with contract delivery timing
  • Bearish factor mix (weak valuation metrics and market skepticism) weighs on outlook

Investment themes with LEU

Uranium +1.46%

OKLO · UEC · NXE.TO

Earnings Call · Q4 2024 · Mgmt. Guidance

Updated 07-15-2026bullish

Transcript signals

Bull points

  • This past quarter, we continued on this progress by winning a DOE contract award for LEU enrichment, further strengthening our capital position by issuing $402.5 million of convertible senior notes, accelerating centrifuge manufacturing preparation while de-risking our American-only supply chain to strengthen our first mover advantage, and delivering to the Department of Energy a total of 545 kgs of HALU to date in Phase 2 of the operations contract.
  • In the fourth quarter, we significantly strengthened our balance sheet by closing over 400 million of convertible notes. This move facilitated our ability to begin investing in our future. And in late November, we announced an approximately $60 million investment to resume centrifuge manufacturing activities and expand our manufacturing capacity at our Oak Ridge facility over the next 18 months.
  • bullish about the need to restore American-owned production of enriched uranium.

Bear points

  • in November, the Russian government revoked the general license that our supplier, Tenex, had for exporting material from Russia to the United States. and now require a specific license for each shipment.
  • We have been informed that Tenex has received three specific licenses to date to export LEU to satisfy our pending orders. We will use the majority of this LEU to satisfy pending orders to a single customer on a delayed basis. Tenex has informed us of its plan to seek additional export licenses to meet its delivery obligations under the Tenex supply contract for our pending and future orders.
  • But all of this will be predicated on government monies.
Read full transcript analysis ›